Encouraging results in the treatment of haemorrhagic cystitis with estrogen - Report of 10 cases and review of the literature

Bone Marrow Transplantation

Volumn 25, Issue 9, 2000, Pages 981-985

  Ordemann, R ^a   Naumann, R ^a   Geissler, G ^a   Bornhauser, M ^a   Schuler, U ^a   Ehninger, G ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Cyclophosphamide; Estrogen; Haematopoietic stem cell transplantation; Haemorrhagic cystitis

Indexed keywords

BUPRENORPHINE; BUSULFAN; CONJUGATED ESTROGEN; CYCLOPHOSPHAMIDE; DIPYRONE; ETOPOSIDE; THYMOCYTE ANTIBODY;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ALLOGRAFT; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DYSURIA; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATURIA; HEMORRHAGIC CYSTITIS; HUMAN; LIVER TOXICITY; MALE; MORBIDITY; MORTALITY; MULTIPLE MYELOMA; PRIORITY JOURNAL; WHOLE BODY RADIATION;

EID: 0034101670     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702380     Document Type: Article

References (32)

1. Brugieres L, Hartmann O, Travagli JP et al. Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course and outcome. J Clin Oncol 1989; 7: 194-199.
2. De Vries CR, Freiha FS. Hemorrhagic cystitis: a review. J Urol 1990; 143: 1-9.
3. Seber A, Shu XO, Defor T et al. Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplant 1999; 23: 35-40.
4. Ilhan O, Koc H, Akan H et al. Hemorrhagic cystitis as a complication of bone marrow transplantation. J Chemother 1997; 9: 56-61.
5. Buchanan W, Bowman JS, Jaffers G. Adenoviral acute hemorrhagic cystitis following renal transplantation. Am J Nephrol 1990; 10: 350-351.
6. Foad B, Hess EV. Urinary bladder complications with CY therapy. Arch Intern Med 1976; 136: 616-619.
7. Trotman J, Nivison-Smith I, Dodds A. Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydration. Bone Marrow Transplant 1994; 23: 797-801.
8. Spencer SF, Haake RJ, Weisdorf DJ. Hemorrhagic cystitis after bone marrow transplantation: risk factors and complications. Transplantation 1993; 56: 875-879.
9. Seber A, Shu XO, Defor T et al. Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplant 1999; 23: 35-40.
10. Klein FA, Smith M. Urinary complications of cyclophosphamide therapy: etiology, prevention and management. South Med J 1983; 76: 1413-1416.
11. Brock N, Stekar J, Pohl J et al. Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sulfosfamide. Arzneim Forsch 1979; 29: 659-661.
12. Stillwell TJ, Benson RC. Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients. Cancer 1988; 61: 451-457.
13. Bearman SI, Appelbaum FR, Buckner CD et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562-1568.
14. Donahue LA, Frank IN. Intravesical formalin for hemorrhagic cystitis: analysis of therapy. J Urol 1989; 141: 809-812.
15. Baronciani D, Angelucci E, Erer B et al. Suprapubic cystotomy as treatment for severe hemorrhagic cystitis after bone marrow transplantation. Bone Marrow Transplant 1995; 16: 267-270.
16. Okaneya T, Kontani K, Komijama I, Takezaki T. Severe cyclophosphamide-induced hemorrhagic cystitis successfully by total cystectomy with ileal neobladder substitution. J Urol 1993; 150: 1909-1910.
17. Miller J, Burfield GD, Moretti K. Oral conjugated estrogen therapy for treatment of hemorrhagic cystitis. J Urol 1994; 151: 1348-1350.
18. Liu YK, Harty JI, Steinbock GX et al. Treatment of radiation or cyclophosphamide induced hemorrhagic cystitis using conjugated estrogen. J Urol 1990; 144: 41-43.
19. Rodriguez Luna JM, Teruel JL, Vallejo J et al. Control of massive hematuria in idiopathic hemorrhagic cystitis after administration of conjugated estrogen. J Urol 1992; 148: 1524-1525.
20. Hows JM, Mehta A, Ward L et al. Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study. Br J Cancer 1984; 50: 753-756.
21. Brock N, Pohl J. The development of mesna for regional detoxification. Cancer Treat Rev 1983; 10 (Suppl. A): 33-43.
22. Mathews R, Rajan N, Josefson L et al. Hyperbaric oxygen therapy for radiation induced hemorrhagic cystitis. J Urol 1999; 161: 435-437.
23. Lupulescu A. Estrogen use and cancer risk: a review. Exp Clin Endocrinol 1993; 101: 204-214.
24. Telang NT, Suto A, Wong GY et al. Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst 1992; 84: 634-638.
25. Grosky RD, Koplan JP, Peterson HB et al. Relative risks and benefits of long-term estrogen replacement therapy: a decision analysis. Obstet Gynecol 1994; 2: 161-166.
26. Daly E, Vessey MP, Hawkins MM et al. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996; 348: 977-980.
27. Deshpande R, Khalili H, Pergolizzi RG et al. Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages. Am J Reprod Immunol 1997; 38: 46-54.
28. Ashcroft GS, Dodsworth J, van Boxtel E et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nature Med 1997; 3: 1209-1215.
29. Ashcroft GS, Greenwell-Wild T, Horan MA et al. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol 1999; 155: 1137-1146.
30. Morales DE, McGowan KA, Grant DS et al. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 1995; 91: 755-763.
31. Krasinski K, Spyridopoulos I, Asahara T et al. Estradiol accelerates functional endothelial recovery after arterial injury. Circulation 1997; 95: 1768-1772.
32. Vance BJ. Hemorrhagic cystitis: failure of estrogen treatment. Urology 1990; 36: 561.